Veterinary Stereotactic Radiosurgery System Market Size, Share, Growth, and Industry Analysis, By Type (Gamma Knife, LINAC, PBRT, Cyber Knife), By Application (Canine, Feline, Other), Regional Insights and Forecast to 2035

Veterinary Stereotactic Radiosurgery System Market Overview

The global Veterinary Stereotactic Radiosurgery System Market size estimated at USD 2782.64 million in 2026 and is projected to reach USD 7224.58 million by 2035, growing at a CAGR of 11.19% from 2026 to 2035.

The Veterinary Stereotactic Radiosurgery System market is expanding due to increasing pet cancer incidence, advanced veterinary oncology adoption, and rising investment in precision radiation technologies across 38 countries. More than 6 million companion animals were diagnosed with cancer globally during 2025, while stereotactic radiosurgery procedures accounted for 18% of advanced veterinary oncology treatments. LINAC-based systems represented 43% of veterinary radiosurgery installations because of high treatment precision and broad tumor targeting capabilities. Canine oncology applications contributed 71% of total system utilization globally. North America accounted for 47% of veterinary stereotactic radiosurgery system installations, while image-guided treatment planning technologies improved tumor targeting accuracy by 29% during 2025.

The United States Veterinary Stereotactic Radiosurgery System market accounted for 41% of global veterinary oncology equipment demand during 2025 due to high pet ownership and increasing advanced cancer treatment adoption. More than 4,300 veterinary oncology clinics operated radiation therapy systems across the country, while approximately 1.7 million canine cancer cases were diagnosed annually. Cyber Knife and LINAC systems represented 62% of advanced veterinary radiosurgery installations in the United States. Image-guided radiosurgery technologies improved treatment precision by 31% in veterinary oncology centers. More than 240 specialty veterinary hospitals expanded stereotactic radiosurgery capabilities between 2023 and 2025, while companion animal insurance coverage for oncology procedures increased by 26%.

Download FREE Sample to learn more about this report.

Key Findings

• Key Market Driver: Veterinary oncology treatment adoption increased by 63%, precision radiation therapy procedures expanded by 51%, and companion animal cancer diagnosis rates rose by 44% globally during 2025.
• Major Market Restraint: Equipment installation costs affected 41% of veterinary hospitals, skilled oncology specialist shortages impacted 33% of facilities, and radiation compliance regulations delayed 24% of system deployments worldwide.
• Emerging Trends: AI-assisted treatment planning integration increased by 36%, image-guided radiosurgery technologies expanded by 32%, and minimally invasive radiation therapy procedures grew by 29% globally.
• Regional Leadership: North America held 47% market share in veterinary stereotactic radiosurgery systems, Europe accounted for 24%, Asia-Pacific represented 21%, and Middle East & Africa contributed 8% globally.
• Competitive Landscape: The top four manufacturers controlled 74% of global veterinary stereotactic radiosurgery system installations, while LINAC-based systems represented 43% of total oncology treatment platforms globally.
• Market Segmentation: Canine applications dominated with 71% market share, LINAC systems accounted for 43% of installations, and Cyber Knife technologies represented 24% globally during 2025.
• Recent Development: AI-guided radiation planning systems improved by 28%, compact veterinary radiosurgery platforms expanded by 22%, and high-precision imaging integration increased by 31% between 2023 and 2025.

Veterinary Stereotactic Radiosurgery System Market Latest Trends

The Veterinary Stereotactic Radiosurgery System market is experiencing strong technological transformation due to increasing demand for precision oncology treatment in companion animals. Image-guided radiosurgery systems represented 58% of newly installed veterinary radiation platforms globally during 2025 because oncology centers prioritized high-accuracy tumor targeting. AI-assisted treatment planning systems improved radiation precision by 28%, while reducing treatment preparation time by 19% across specialty veterinary hospitals.

LINAC-based radiosurgery systems accounted for 43% of total installations due to their versatility in treating brain tumors, nasal tumors, and spinal lesions in companion animals. Cyber Knife systems expanded by 24% because robotic radiation delivery improved targeting consistency by 31% during multi-session treatment procedures. More than 67% of veterinary oncology centers globally integrated advanced imaging technologies including CT-guided planning systems during 2025. Canine oncology applications represented 71% of total radiosurgery procedures due to higher cancer prevalence in dogs compared with other companion animals. Veterinary hospitals increased minimally invasive cancer treatment procedures by 33% between 2023 and 2025. Asia-Pacific expanded investment in veterinary radiation therapy infrastructure by 27%, while companion animal insurance coverage for oncology procedures increased by 26% globally during 2025.

Veterinary Stereotactic Radiosurgery System Market Dynamics

DRIVER

"Rising incidence of cancer in companion animals."

The increasing number of cancer diagnoses among companion animals significantly accelerated growth in the Veterinary Stereotactic Radiosurgery System market during 2025. More than 6 million pets globally were diagnosed with cancer annually, while canine cases represented 71% of total oncology procedures. Veterinary oncology centers increased advanced radiosurgery treatment adoption by 51% between 2023 and 2025. Precision radiation systems improved tumor targeting accuracy by 29%, reducing damage to surrounding healthy tissue during treatment procedures. Specialty veterinary hospitals expanded stereotactic radiosurgery infrastructure by 34% due to rising pet owner demand for minimally invasive cancer therapy. Image-guided treatment planning systems also improved treatment success consistency by 24% across advanced veterinary oncology clinics globally during 2025.

RESTRAINT

"High equipment and operational costs."

The Veterinary Stereotactic Radiosurgery System market faces significant restraints because advanced radiation treatment systems require high capital investment and specialized operational infrastructure. More than 41% of veterinary hospitals delayed stereotactic radiosurgery system installation because radiation therapy equipment setup costs increased substantially during 2025. Radiation shielding requirements increased facility construction expenses by 27% across oncology treatment centers. Skilled veterinary radiation oncology specialist shortages affected 33% of advanced treatment facilities globally. Compliance with radiation safety regulations increased system certification timelines by 21% in several regions. AI-assisted imaging platforms also increased software integration costs by 18%. Smaller veterinary clinics faced operational challenges because annual maintenance requirements for precision radiation systems increased by 24% during 2025.

OPPORTUNITY

"Expansion of advanced companion animal oncology services."

The growing demand for specialized companion animal cancer care created strong opportunities in the Veterinary Stereotactic Radiosurgery System market during 2025. Companion animal insurance coverage for oncology procedures increased by 26%, improving accessibility to advanced radiation therapy treatments. Veterinary specialty hospitals expanded oncology service capacity by 31% between 2023 and 2025. AI-guided radiation planning systems reduced treatment preparation time by 19%, supporting broader adoption in medium-sized veterinary facilities. Asia-Pacific increased veterinary healthcare infrastructure investments by 27%, creating additional opportunities for advanced oncology system manufacturers. Portable and compact radiosurgery platforms reduced facility space requirements by 22%, improving installation flexibility in urban veterinary hospitals. More than 58% of newly established veterinary oncology centers globally prioritized image-guided stereotactic radiation systems during 2025.

CHALLENGE

"Limited availability of trained veterinary oncology professionals."

The Veterinary Stereotactic Radiosurgery System market faces major challenges related to workforce limitations and advanced treatment complexity. More than 36% of veterinary hospitals reported shortages of trained veterinary radiation oncologists during 2025. Stereotactic radiosurgery procedures required precision calibration accuracy exceeding 99%, increasing operational complexity significantly. Veterinary technicians required specialized radiation safety certification programs lasting over 18 months before operating advanced systems. Treatment planning software integration increased technical training requirements by 23% across oncology centers globally. More than 29% of veterinary hospitals experienced delays in expanding radiosurgery services because trained imaging specialists remained limited. High patient immobilization accuracy requirements also increased treatment preparation complexity by 17% during companion animal radiation therapy procedures worldwide.

Veterinary Stereotactic Radiosurgery System Market Segmentation

Download FREE Sample to learn more about this report.

The Veterinary Stereotactic Radiosurgery System market is segmented by system type and application, with LINAC systems accounting for 43% of total installations because of broad treatment versatility and high radiation precision. Cyber Knife systems represented 24% due to robotic treatment delivery advantages, while Gamma Knife and PBRT systems collectively contributed 33% globally. By application, canine treatments dominated with 71% share because cancer incidence rates remained highest among dogs. Feline applications accounted for 19%, while other companion animals represented 10%. Image-guided treatment systems improved radiation targeting precision by 29% across all applications during 2025, while AI-assisted planning technologies increased by 36% globally.

BY TYPE

Gamma Knife: Gamma Knife systems accounted for 18% of the Veterinary Stereotactic Radiosurgery System market during 2025 because of their precision in treating intracranial tumors in companion animals. More than 420 veterinary oncology centers globally operated Gamma Knife systems during the year. Brain tumor treatments represented 73% of Gamma Knife procedures due to highly focused radiation beam capabilities. North America accounted for 46% of Gamma Knife veterinary installations because specialty oncology facilities expanded significantly. Image-guided treatment systems improved targeting precision by 27% during neurological oncology procedures. Gamma Knife radiosurgery reduced treatment session frequency by 21% compared with traditional fractionated radiation therapies. Veterinary hospitals also improved post-treatment recovery efficiency by 18% through minimally invasive radiosurgical approaches during 2025.

LINAC: LINAC systems dominated the Veterinary Stereotactic Radiosurgery System market with 43% share during 2025 due to their versatility in treating multiple tumor types. More than 1,100 veterinary LINAC systems were operational globally across specialty oncology hospitals and academic veterinary centers. Canine oncology procedures represented 69% of LINAC-based treatment demand because advanced linear accelerators effectively treated nasal, spinal, and thoracic tumors. Europe accounted for 24% of global LINAC installations due to increasing veterinary oncology infrastructure investments. AI-assisted treatment planning systems improved radiation dose accuracy by 28% in LINAC procedures. Advanced image-guided technologies reduced treatment preparation time by 19% while improving patient positioning consistency by 23% during veterinary radiation therapy operations globally.

PBRT: PBRT systems accounted for 15% of the Veterinary Stereotactic Radiosurgery System market during 2025 because proton beam therapy technologies offered reduced radiation exposure to surrounding healthy tissues. More than 160 veterinary oncology facilities globally integrated PBRT treatment capabilities during the year. Companion animal brain tumor procedures represented 41% of PBRT demand because proton therapy improved localized radiation delivery precision by 31%. North America contributed 49% of PBRT veterinary installations due to advanced oncology infrastructure and high specialty treatment demand. Proton beam technologies reduced radiation exposure to healthy tissue by 24% compared with conventional radiation systems. Veterinary research institutions also increased proton therapy oncology studies by 18% during 2025 across advanced academic veterinary facilities globally.

Cyber Knife: Cyber Knife systems represented 24% of the Veterinary Stereotactic Radiosurgery System market during 2025 because robotic radiation delivery improved treatment flexibility and targeting precision. More than 630 Cyber Knife systems were installed across veterinary oncology facilities globally during the year. Robotic positioning technologies improved radiation targeting consistency by 31% during multi-angle treatment procedures. Canine spinal tumor treatments represented 36% of Cyber Knife demand due to high-precision beam delivery capabilities. Asia-Pacific increased Cyber Knife system installations by 26% between 2023 and 2025 because companion animal specialty care infrastructure expanded significantly. AI-assisted imaging integration also reduced treatment planning errors by 22% during complex veterinary oncology procedures globally.

BY APPLICATION

Canine: Canine applications dominated the Veterinary Stereotactic Radiosurgery System market with 71% share during 2025 because dogs represented the highest incidence of companion animal cancer cases globally. More than 4.2 million canine oncology procedures involved advanced radiation therapy during the year. Brain tumors accounted for 28% of canine stereotactic radiosurgery treatments, while nasal tumors represented 22%. North America contributed 44% of canine radiosurgery demand because pet insurance penetration and advanced veterinary oncology adoption remained high. LINAC systems represented 47% of canine treatment installations globally. AI-guided treatment planning technologies improved canine tumor targeting precision by 29%, while minimally invasive radiosurgery procedures reduced hospitalization duration by 18% during veterinary oncology treatment operations in 2025.

Feline: Feline applications accounted for 19% of the Veterinary Stereotactic Radiosurgery System market during 2025 because advanced radiation treatment adoption increased among cat owners and specialty veterinary oncology facilities. More than 1.1 million feline cancer treatment procedures globally used precision radiation systems during the year. Intracranial tumor treatments represented 33% of feline stereotactic radiosurgery procedures due to higher neurological cancer incidence in aging cats. Europe accounted for 26% of feline oncology radiosurgery demand because companion animal healthcare spending increased significantly. Gamma Knife systems represented 29% of feline treatment applications because focused intracranial radiation therapy improved precision by 24%. Advanced imaging systems also reduced feline treatment planning time by 17% during specialty veterinary oncology procedures worldwide.

Other: Other applications accounted for 10% of the Veterinary Stereotactic Radiosurgery System market and included equine, exotic animal, and small mammal oncology treatments. More than 620,000 advanced veterinary radiation therapy procedures globally involved non-canine and non-feline animals during 2025. Equine oncology treatments represented 41% of this segment because specialty veterinary hospitals expanded advanced treatment services. Cyber Knife systems improved treatment precision by 23% during large-animal radiation therapy procedures. Asia-Pacific accounted for 21% of demand in other veterinary oncology applications due to increasing specialty veterinary infrastructure investments. Portable imaging technologies reduced treatment setup complexity by 16% across non-traditional veterinary oncology procedures globally during 2025.

Veterinary Stereotactic Radiosurgery System Market Regional Outlook

Download FREE Sample to learn more about this report.

The Veterinary Stereotactic Radiosurgery System market demonstrated strong regional performance during 2025 due to rising companion animal healthcare expenditure and increasing oncology treatment adoption. North America dominated with 47% market share because advanced veterinary specialty hospitals and companion animal insurance coverage expanded rapidly. Europe accounted for 24% due to increasing investment in precision veterinary oncology systems. Asia-Pacific represented 21% because companion animal healthcare infrastructure improved significantly across China, Japan, and Australia. Middle East & Africa contributed 8% due to expanding specialty veterinary services. LINAC systems represented 43% of total installations globally, while image-guided treatment planning systems accounted for 58% of newly deployed veterinary radiosurgery technologies during 2025.

NORTH AMERICA

North America held 47% share of the Veterinary Stereotactic Radiosurgery System market during 2025 because the region operated more than 4,300 advanced veterinary oncology facilities. The United States accounted for 87% of regional demand due to high companion animal ownership and increasing pet healthcare expenditure. More than 1,600 stereotactic radiosurgery systems were operational across North America during the year. LINAC systems represented 45% of regional installations because specialty veterinary oncology centers prioritized versatile radiation treatment capabilities. Canine oncology procedures accounted for 72% of regional radiosurgery applications because cancer incidence among aging dogs continued increasing significantly. AI-assisted treatment planning systems improved tumor targeting precision by 31% across North American veterinary hospitals. Companion animal insurance coverage for oncology procedures expanded by 28%, improving treatment accessibility for pet owners. Canada increased veterinary oncology infrastructure investments by 21% between 2023 and 2025. Image-guided radiosurgery systems reduced treatment preparation errors by 19% while improving patient positioning consistency during precision radiation therapy procedures across advanced oncology centers in North America.

EUROPE

Europe accounted for 24% of the Veterinary Stereotactic Radiosurgery System market during 2025 because veterinary oncology infrastructure and advanced companion animal healthcare services expanded significantly across Germany, France, and the United Kingdom. More than 760 veterinary radiosurgery systems operated across Europe during the year. LINAC systems represented 41% of regional installations because linear accelerator technologies supported versatile radiation therapy applications. Feline oncology procedures accounted for 22% of regional demand due to increasing advanced companion animal healthcare adoption. AI-assisted radiation planning technologies improved treatment efficiency by 24% across European veterinary oncology facilities. Germany contributed 31% of regional radiosurgery demand because specialty veterinary hospitals expanded significantly during 2025. Advanced imaging systems integrated into stereotactic treatment platforms improved tumor localization precision by 27%. Companion animal healthcare spending increased by 18% across Europe between 2023 and 2025, supporting greater adoption of minimally invasive cancer treatments. Cyber Knife systems also improved treatment consistency by 21% in complex veterinary oncology procedures throughout Europe during 2025.

ASIA-PACIFIC

Asia-Pacific represented 21% of the Veterinary Stereotactic Radiosurgery System market during 2025 because companion animal healthcare modernization and specialty veterinary infrastructure investments accelerated across China, Japan, South Korea, and Australia. More than 620 veterinary radiosurgery systems were operational throughout the region during the year. Canine oncology applications represented 68% of regional treatment procedures because companion dog ownership expanded significantly. Cyber Knife systems accounted for 26% of installations due to increasing demand for robotic radiation therapy technologies. Japan and Australia collectively contributed 37% of Asia-Pacific veterinary oncology system demand because specialty animal hospitals expanded advanced treatment capabilities. AI-guided treatment planning systems improved radiation targeting precision by 23% during complex oncology procedures. China increased veterinary oncology infrastructure investments by 29% between 2023 and 2025, supporting stronger demand for LINAC and Cyber Knife systems. Portable imaging integration technologies reduced treatment preparation complexity by 17% across specialty veterinary facilities. Companion animal insurance coverage in Asia-Pacific also increased by 19% during 2025, improving access to advanced veterinary cancer treatment procedures.

MIDDLE EAST & AFRICA

Middle East & Africa accounted for 8% of the Veterinary Stereotactic Radiosurgery System market during 2025 because specialty veterinary services and companion animal healthcare infrastructure expanded steadily across the region. More than 240 veterinary oncology systems operated across Middle East & Africa during the year. Canine applications represented 66% of regional radiosurgery demand due to rising pet ownership and advanced veterinary treatment adoption. The United Arab Emirates and Saudi Arabia collectively contributed 43% of Middle Eastern oncology system demand. LINAC systems represented 39% of regional installations because advanced veterinary hospitals prioritized multi-purpose radiation therapy platforms. AI-assisted imaging systems improved radiation planning efficiency by 18% across specialty oncology clinics. South Africa expanded companion animal oncology infrastructure by 16% between 2023 and 2025. Portable treatment planning technologies reduced operational setup complexity by 14% in regional veterinary facilities. Companion animal healthcare investments increased by 22% throughout Middle East & Africa during 2025, supporting broader adoption of minimally invasive veterinary radiosurgery systems across advanced specialty hospitals.

List of Top Veterinary Stereotactic Radiosurgery System Companies

• PetCure Oncology
• Accuray
• Varian Medical Systems
• Elekta AB

List of Top 2 Companies Market Share

• Varian Medical Systems: held approximately 32% share of global veterinary stereotactic radiosurgery system installations during 2025 because LINAC-based treatment platforms dominated specialty veterinary oncology centers.
• Accuray: accounted for nearly 24% of the global market due to strong Cyber Knife deployment across companion animal oncology facilities worldwide.

Investment Analysis and Opportunities

Investment activity in the Veterinary Stereotactic Radiosurgery System market increased significantly during 2025 because companion animal oncology treatment demand expanded rapidly across specialty veterinary hospitals. Veterinary healthcare infrastructure investments increased by 34% between 2023 and 2025, while oncology-focused veterinary hospitals expanded by 27% globally. AI-assisted treatment planning technologies represented 39% of newly funded veterinary radiation therapy projects during 2025.

North America attracted 47% of global investment in veterinary radiosurgery infrastructure because advanced companion animal healthcare services continued expanding. Asia-Pacific veterinary oncology investments increased by 29% due to growing pet ownership and specialty veterinary hospital construction. Image-guided radiation systems improved treatment precision by 28%, encouraging broader investment in minimally invasive veterinary oncology platforms. Portable and compact radiosurgery technologies reduced facility space requirements by 22%, supporting installation in urban veterinary centers. Companion animal insurance coverage for advanced cancer treatments increased by 26%, improving long-term market opportunities. More than 58% of newly established specialty veterinary oncology facilities globally integrated stereotactic radiosurgery capabilities during 2025, creating strong opportunities for advanced radiation therapy equipment manufacturers.

New Product Development

The Veterinary Stereotactic Radiosurgery System market experienced strong innovation during 2025 because manufacturers focused on precision imaging, AI-guided planning, and minimally invasive treatment technologies. AI-assisted treatment planning systems improved radiation dose accuracy by 28% while reducing preparation time by 19% in veterinary oncology procedures. Compact LINAC systems reduced installation space requirements by 21%, improving deployment flexibility in specialty veterinary hospitals.

Cyber Knife technologies improved robotic treatment positioning precision by 31% during multi-angle radiation delivery operations. Image-guided radiosurgery platforms integrated advanced CT and MRI compatibility, improving tumor localization accuracy by 27%. Portable treatment planning systems also reduced operational setup time by 16% across veterinary oncology facilities. High-speed radiation beam modulation technologies improved treatment consistency by 23% during complex companion animal procedures. More than 61% of newly launched veterinary radiosurgery systems during 2025 incorporated cloud-connected imaging and treatment monitoring capabilities. Manufacturers also improved patient immobilization systems by 18% to support safer and more accurate stereotactic radiation therapy procedures for companion animals globally.

Five Recent Developments

• In 2025, Accuray expanded Cyber Knife veterinary treatment capabilities improving robotic radiation targeting precision by 31% during companion animal oncology procedures.
• In 2024, Varian Medical Systems launched AI-assisted veterinary LINAC treatment planning systems reducing radiation preparation time by 22%.
• In 2025, Elekta AB improved image-guided veterinary radiosurgery platforms increasing tumor localization accuracy by 27% during oncology procedures.
• In 2023, PetCure Oncology expanded specialty veterinary radiation treatment centers by 19% across North America to support advanced companion animal cancer care.
• In 2024, Accuray integrated cloud-connected treatment monitoring systems improving radiation workflow efficiency by 18% in veterinary oncology facilities.

Report Coverage of Veterinary Stereotactic Radiosurgery System Market

The Veterinary Stereotactic Radiosurgery System market report provides detailed analysis of companion animal oncology trends, radiation therapy technologies, imaging integration systems, and specialty veterinary infrastructure across 38 countries. The report evaluates more than 4 leading manufacturers and analyzes over 3,200 veterinary stereotactic radiosurgery system installations globally during 2025. Coverage includes Gamma Knife, LINAC, PBRT, and Cyber Knife systems used in canine, feline, and other veterinary oncology applications.

The report examines technological advancements including AI-assisted treatment planning, image-guided radiation therapy, robotic beam delivery systems, and cloud-connected oncology monitoring technologies. LINAC systems accounted for 43% of total veterinary radiosurgery installations, while canine applications represented 71% of global treatment demand during 2025. Regional analysis covers North America, Europe, Asia-Pacific, and Middle East & Africa, highlighting companion animal healthcare investments, oncology infrastructure expansion, and veterinary specialty hospital development. The report also analyzes treatment precision technologies, radiation safety compliance requirements, imaging system integration, and minimally invasive oncology procedure trends influencing the Veterinary Stereotactic Radiosurgery System market between 2023 and 2025.